NCT04354467View on ClinicalTrials.gov

Assessment of Urinary Neutrophil Gelatinase-Associated Lipocalin to Predict AKI in the NICU

CompletedOBSERVATIONAL
Enrollment

148

Participants

Timeline

Start Date

January 28, 2019

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2023

Conditions
Acute Kidney InjuryNephrotoxicityNeonatal
Interventions
DIAGNOSTIC_TEST

urine neutrophil gelatinase -associated lipocalin

urine biomarker is measured and batched procesessed

Trial Locations (2)

35233

Children's of Alabama, Birmingham

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

lead

University of Alabama at Birmingham

OTHER

NCT04354467 - Assessment of Urinary Neutrophil Gelatinase-Associated Lipocalin to Predict AKI in the NICU | Biotech Hunter | Biotech Hunter